Leenders, A.C.A.P.

patient infection ambisome amphotericin aspergillosi amphotericin b study treatment neoforman strain number cryptococcal meningitis aspergillu result conidia neoformans var chapter cryptococcal meningiti hospital formulation fumigatu sample therapy hematology table animal efficacy response species antifungal liposomal amphotericin b outbreak period lipid liposomal analysis agent disease amphotericin b lipid culture cryptococcus neoformans hematology ward cryptococcu difference fungi toxicity department epidemiology typing fluconazole laboratory fungizone microbiol pattern amphotericin b deoxycholate chemother lipid formulations antimicrob serum hiv-infected patients air samples factor model dissemination neutropenic patients surveillance mortality aspergillus spp rapd analysis rotterdam group source dosage neutropenic csf culture conversion density outcome method level